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:10.1Summary
An 8-year-old crossbred dog was presented with a one-month history of progressive weakness, respiratory im-
pairment and abdominal distension. Surgical exploration revealed the presence of a splenic mass that inﬁl-
trated the mesentery and was adherent to the stomach and pancreas. The mass was composed of highly
cellular areas of spindle-shaped cells arranged in interlacing bundles, streams, whorls and storiform patterns
(Antoni A pattern) and less cellular areas with more loosely arranged spindle to oval cells (Antoni B pattern).
The majority of neoplastic cells expressed vimentin, S-100 and glial ﬁbrillary acidic protein (GFAP), but did
not express desmin, a-smooth muscle actin or factor VIII. These morphological and immunohistochemical
ﬁndings characterized the lesion as a malignant peripheral nerve sheath tumour (PNST). Primary splenic
PNST has not been documented previously in the dog.
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a heterogeneous group of lesions classiﬁed into benign
schwannoma, benign neuroﬁbroma, malignant
schwannoma and neuroﬁbrosarcoma (Hendrick
et al., 1998; Koestner et al., 1999). Schwannomas orig-
inate from Schwann cells only, whereas neuroﬁ-
bromas and neuroﬁbrosarcomas are mixed tumours
composed of Schwann cells and perineural cells (Hen-
drick et al., 1998; Goldschmidt and Hendrick, 2002).
Some authors, however, prefer to distinguish only be-
tween benign and malignant PNSTs (Hendrick et al.,
1998; Goldschmidt and Hendrick, 2002) since
differential diagnosis based upon morphology alone
is difﬁcult.
PNSTs are uncommon in animals and occurmostly
in dogs, cattle and cats (Summers et al., 1995; Hen-
drick et al., 1998; Goldschmidt and Hendrick, 2002).
Benign PNSTs (BPNSTs) of the nervous system are
rare in dogs and cats and are found incidentally in
cattle (Summers et al., 1995; Koestner et al., 1999).
Malignant PNSTs (MPNSTs) of the nervous systemondence to: M. Welle (e-mail: monika.welle@itpa.unibe.ch).
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016/j.jcpa.2009.03.009are most commonly seen in dogs (Koestner et al.,
1999).
Benign PNSTs of the skin are uncommon in cats
and rare in dogs (Hendrick et al., 1998). In cattle,
multiple benign cutaneous PNSTs may arise within
the subcutis and the nerve plexuses (Hendrick et al.,
1998; Goldschmidt and Hendrick, 2002). Malignant
cutaneous PNSTs are uncommon in cats and ex-
tremely rare in large animals (Goldschmidt and Hen-
drick, 2002). The true incidence of canine dermal
malignant PNST is difﬁcult to estimate since conﬁr-
mation of the diagnosis requires immunohistochemi-
cal examination that was not performed routinely in
the past.
Although rare, PNSTs arising within the thoracic
cavity and abdomen have been described in man
(Bui et al., 2004; Khan et al., 2006; Rahman et al.,
2006; Vyas et al., 2006; Tashiro et al., 2007), horses
(Pascoe, 1982; Andreasen et al., 1993; Kirchhof
et al., 1996; Stoica et al., 2001; Quinn et al., 2005),
dogs (Stoica et al., 2001; Essman et al., 2002; Aupperle
et al., 2007; Patterson et al., 2008; Sugiyama et al.,
2008), cats (Stoica et al., 2001) and cattle (Stoica
et al., 2001). Herein we report the clinical, 2009 Elsevier Ltd. All rights reserved.
196 W. Bergmann et al.microscopical and immunohistochemical ﬁndings re-
lated to the occurrence of a PNSTwithin the spleen of
a dog. To the best of our knowledge, primary splenic
PNSTs have not been described previously in man or
animals.
An 8-year-old, neutered female, crossbred dog was
presented with a one month history of progressive
weakness, respiratory impairment and abdominal
distension. Clinical examination revealed loss of gen-
eral body condition, mild hypothermia (body tem-
perature 37.6C), low heart rate (64 beats/min) and
a generalized mild increase in lung sounds on inspira-
tion. The abdomen was distended, with palpable en-
largement of the spleen. Haematological and serum
biochemical examinations revealed the presence of
a stress leucogram, thrombocytosis andmild hypogly-
caemia. The urinary sediment was unremarkable. Ul-
trasonography conﬁrmed the presence of a large
splenic mass, with suspected rupture but minimal
peritoneal effusion. There were no lesions suggestive
of metastasis on thoracic radiography. On laparot-
omy, the mass was seen to inﬁltrate the mesentery
and was attached to the fundic area of the gastric
wall and to the distal left limb of the pancreas
(Fig. 1). Aberrant vessels had formed between the
splenic mass and the caudal pole of the left kidney.
The tumour was dissected from the surrounding tissue
and the aberrant vascular trunk ligated. After partial
gastrectomy and pancreatectomy, the tumour was
completely excised and had a weight of 600 g. Follow-Fig. 1. Splenic tumour during surgery. The mass inﬁltrates the
mesentery and is attached to the stomach and thepancreas.ing discharge, the dog remained well for three
months, but thereafter started to vomit. An ultra-
sound examination at this time revealed the presence
of masses within the liver andmesentery. The dog was
humanely destroyed without permission for necropsy
examination.
The excised spleen contained a non-encapsulated,
multilobulated, inﬁltrative, marbled mass (5 7.5
 11 cm) of soft consistency. Representative samples
taken from the lesion were ﬁxed in 10% neutral buff-
ered formalin, processed routinely and sections were
stained with haematoxylin and eosin (HE). Serial sec-
tions were subject to immunohistochemical examina-
tion with the following primary antibodies (all from
Dako, Glostrup, Denmark unless otherwise stated):
rabbit polyclonal anti-factor VIII (1 in 400), rabbit
polyclonal anti-S-100 (1 in 400; Zymed, San Fran-
cisco, USA), mouse monoclonal anti-Desmin (1 in
200; Novocastra Ltd, Newcastle UK), mouse anti-a-
smoothmuscle actin (1 in 2000), mouse anti-vimentin
(1 in 20,000; Sigma, St Louis, USA), mouse anti-glial
ﬁbrillary acidic protein (GFAP; 1 in 3000) and rabbit
polyclonal anti-human c-kit (1 in 200). Secondary de-
tection was performed with an avidinebiotineperox-
idase kit according to the manufacturer’s instructions
(Vector laboratories, Burlingame, CA, USA).
Microscopically, the mass was non-encapsulated,
poorly demarcated and replaced the majority of the
splenic parenchyma. Neoplastic tissue inﬁltrated the
surrounding adipose tissue and mesentery. The mass
had a biphasic growth pattern. Some regions were
highly cellular and composed of interlacing bundles
and streams of spindle-shaped cells growing in a stori-
form pattern or as whorls around blood vessels and
nerves. These cells had poorly deﬁned eosinophilic ﬁ-
brillar cytoplasm and spindle-shaped basophilic nu-
clei and were associated with variable amounts of
collagenous stroma (Antoni A pattern; Fig. 2). Other
areas were less cellular and composed of loosely ar-
ranged spindle to oval cells with inconspicuous cyto-
plasm and a small hyperchromatic round nucleus
surrounded by a copious myxoid, often microcystic,
matrix (Antoni B pattern). In these areas numerous
lymphatic vessels were markedly dilated (Fig. 3).
The mitotic rate in both areas was less than one per
400 high-power ﬁeld. Immunohistochemical label-
ling revealed that almost 100% of the neoplastic cells
expressed cytoplasmic vimentin, S-100 and GFAP
(Fig. 4), but there was no expression of desmin, a-
smooth muscle actin, factor VIII or c-kit. These ﬁnd-
ings supported a diagnosis of a primary splenic malig-
nant PNST.
On the basis of morphological appearance it is dif-
ﬁcult to differentiate PNST from other mesenchymal
tumours, particularly those of perivascular origin
Fig. 4. Neoplastic spindle cells with cytoplasmic expression of
GFAP. IHC. Bar, 50 mm.
Fig. 2. Highly cellular area composed of interlacing bundles,
streams and whorls of spindle-shaped cells (Antoni A pat-
tern). HE. Bar, 50 mm.
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2002). Deﬁnitive diagnosis requires immunohisto-
chemistry (IHC), electron microscopy or genetic
analysis (Stoica et al., 2001). No speciﬁc immunohis-
tochemical markers are able to deﬁne a PNST, so
a panel of reagents is generally employed. PNSTs
are, like all spindle cell tumours, positive for vimentin,
indicating a mesenchymal origin (Pe´rez et al., 1996;
Chijiwa et al., 2004). S-100 identiﬁes Schwann cells
and consequently most PNSTs express this molecule
(Koestner et al., 1999; Chijiwa et al., 2004). There
may be variable expression of GFAP, nerve growth
factor receptor (NGFR) and neuron speciﬁc enolase
(NSE) (Koestner and Higgins, 2002; Chijiwa et al.,
2004). However, other tumours may also express the
combination of S-100, GFAP, NGFR and NSE (Chi-
jiwa et al., 2004). The inclusion of antibodies speciﬁcFig. 3. Area of less cellular, more loosely arranged spindle cells,
surrounded by a copious myxoid matrix (Antoni B pat-
tern). HE. Bar, 50 mm.for factor VIII, desmin and a-smooth muscle actin
in the diagnostic panel can assist in distinguishing tu-
mours of vascular or myoﬁbroblastic origin. Use of
immunolabelling for c-kit can exclude the possibility
of gastrointestinal stromal tumour (GIST). In the
present case, conﬁrmation of the identity of this tu-
mour was only made possible following evaluation
of the lesion immunohistochemicallywith such apanel
of antisera.Acknowledgment
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